Callos Andrew bought CYTK

May 1, 2026 · Form 4 insider transaction

Callos Andrew bought 15,857 shares of Cytokinetics, Incorporated at $37.63 per share, a transaction worth $596.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.